Date | Name | Shares | Transaction | Value |
May 15, 2024
| Jason Kilgore See Remarks |
111,219
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $18 per share |
2,001,942.00
|
May 15, 2024
| Jason Kilgore See Remarks |
100,009
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $40.4 per share |
4,040,363.60
|
May 15, 2024
| Jason Kilgore See Remarks |
60,630
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $40.15 per share |
2,434,294.50
|
May 15, 2024
| Jason Kilgore See Remarks |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 11, 2024
| Anne M. Cooney Director |
3,341
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2024
| Karli Schumaker Anderson See Remarks |
34,731
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2024
| Karli Schumaker Anderson See Remarks |
29,733
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $42.39 per share |
1,260,381.87
|
Mar 11, 2024
| Karli Schumaker Anderson See Remarks |
13,589
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2024
| Anne P. Noonan President & CEO; Director |
71,479
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2024
| David Loomes See Remarks |
13,974
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2024
| Irene Moshouris Director |
3,341
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2024
| Susan A. Ellerbusch Director |
3,341
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2024
| Steven H. Wunning Director |
3,341
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2024
| Anne P. Noonan President & CEO; Director |
295,137
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2024
| Jason Kilgore See Remarks |
13,203
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2024
| Brian D. Frantz See Remarks |
2,839
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2024
| Anne P. Noonan President & CEO; Director |
259,394
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $42.39 per share |
10,995,711.66
|
Mar 11, 2024
| Howard L. Lance Director |
3,341
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2024
| Joseph S. Cantie Director |
3,341
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2024
| Anne K. Wade Director |
3,341
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|